A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

Although surveys have found that few clinicians discuss cannabis use with their patients, experts make the case why they ...

Cannabis is gaining widespread appeal and a growing number of U.S. states are approving medical marijuana. A large study ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...

Recent health news covers various topics: a new mpox case in New York, promising results of Ozempic for alcohol use disorder, U.S. impact on global health funding, Robert F. Kennedy Jr.'s health ...

Overuse of high-potency cannabis could be linked to a sharp increase in schizophrenia cases in Canada, according to a new ...

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and ...

Chronic health conditions are having a serious, negative impact on the welfare of the country's workers and their output, a ...